BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27465291)

  • 1. Melanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells.
    Touil Y; Segard P; Ostyn P; Begard S; Aspord C; El Machhour R; Masselot B; Vandomme J; Flamenco P; Idziorek T; Figeac M; Formstecher P; Quesnel B; Polakowska R
    Sci Rep; 2016 Jul; 6():30405. PubMed ID: 27465291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway.
    Bai M; Zhang M; Long F; Yu N; Zeng A; Zhao R
    Oncol Rep; 2017 May; 37(5):2702-2710. PubMed ID: 28358423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
    Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
    Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic Breast Cancer Cells Enter Into Dormant State and Express Cancer Stem Cells Phenotype Under Chronic Hypoxia.
    Carcereri de Prati A; Butturini E; Rigo A; Oppici E; Rossin M; Boriero D; Mariotto S
    J Cell Biochem; 2017 Oct; 118(10):3237-3248. PubMed ID: 28262977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.
    Rossari F; Zucchinetti C; Buda G; Orciuolo E
    Cell Oncol (Dordr); 2020 Apr; 43(2):155-176. PubMed ID: 31392521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis.
    Contador-Troca M; Alvarez-Barrientos A; Merino JM; Morales-Hernández A; Rodríguez MI; Rey-Barroso J; Barrasa E; Cerezo-Guisado MI; Catalina-Fernández I; Sáenz-Santamaría J; Oliver FJ; Fernandez-Salguero PM
    Mol Cancer; 2015 Aug; 14():148. PubMed ID: 26242870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy.
    Jia Q; Yang F; Huang W; Zhang Y; Bao B; Li K; Wei F; Zhang C; Jia H
    Theranostics; 2019; 9(2):424-435. PubMed ID: 30809284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activity.
    Touil Y; Zuliani T; Wolowczuk I; Kuranda K; Prochazkova J; Andrieux J; Le Roy H; Mortier L; Vandomme J; Jouy N; Masselot B; Ségard P; Quesnel B; Formstecher P; Polakowska R
    Stem Cells; 2013 Apr; 31(4):641-51. PubMed ID: 23355370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities.
    Hen O; Barkan D
    Semin Cancer Biol; 2020 Feb; 60():157-165. PubMed ID: 31491559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma.
    Dong Z; Yang J; Li L; Tan L; Shi P; Zhang J; Zhong X; Ge L; Wu Z; Cui H
    Int J Oncol; 2020 Mar; 56(3):728-742. PubMed ID: 32124950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs).
    Bartosh TJ; Ullah M; Zeitouni S; Beaver J; Prockop DJ
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6447-E6456. PubMed ID: 27698134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
    Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
    BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell dormancy and tumor refractory.
    Wang K; Jiang W; Cheng C; Li Y; Tu M
    Anticancer Agents Med Chem; 2013 Feb; 13(2):1312-1316. PubMed ID: 22934702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z; Paul BT; Craft B; ElShamy WM
    Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dormancy of metastatic melanoma.
    Ossowski L; Aguirre-Ghiso JA
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):41-56. PubMed ID: 19843243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models.
    Lee HL; Park MH; Song JK; Jung YY; Kim Y; Kim KB; Hwang DY; Yoon do Y; Song MJ; Han SB; Hong JT
    Oncotarget; 2016 Apr; 7(17):23425-38. PubMed ID: 26993600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.
    Sunayama J; Sato A; Matsuda K; Tachibana K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Stem Cells; 2011 Sep; 29(9):1327-37. PubMed ID: 21793107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.